Status epilepticus: Will we capture the moment or continue without evidence of efficacy or costs?

Neurology. 2019 May 14;92(20):931-932. doi: 10.1212/WNL.0000000000007494.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anticonvulsants*
  • Cost-Benefit Analysis
  • Humans
  • Status Epilepticus*

Substances

  • Anticonvulsants